Merck & Company
- MRK
- NYSE
- Consumer Products
- Latest 46.71
- Currency US$
- Change -0.62
- Percent Change -1.31 %
- Volume 42,629,592
- Wed May 22, 2013 4:00 PM EDT NYSE data delayed 15 minutes.
The Globe and Mail
- Open 47.60
- Previous Close 47.33
- High 48.30
- Low 46.49
- Bidx0 46.52
- Askx0 47.08
- 52-week High 04/24 48.79
- 52-week Low 06/01 37.02
- Beta 0.409
- Market Cap 141,174.90M
- EPS 3.68
- P/E 12.69
- Forward P/E 12.357
- PEG 5.03
- Annual Dividend 1.72
- Yield 3.682
News
- Analysis: Drugmakers face more scrutiny of discordant U.S. prices
- PRESS DIGEST-New York Times business news - May 10
- Merck sales rep files lawsuit alleging company discriminates against women
- UPDATE 2-Merck sales rep claims sexual bias, seeks over $100 mln
- Merck sales rep alleges sexual bias, seeks over $100 mln
- Merck Statement on FDA Advisory Committee Meeting for Suvorexant
- Merck Announces $5 Billion Accelerated Share Repurchase
- Merck to Present at the UBS Global Healthcare Conference
- Global Health, Development and Business Leaders Announce New Innovative Financing Partnership to Deliver Essential Health Supplies More Quickly and Efficiently
- Merck Prices $ 6.5 Billion Debt Offering
Financials & Calendars
- Sales $46,208,000,000
- Earnings $6,516,000,000
- Return on Equity 11.73%
- Cash Flow --
- Cash $13,024,000,000
- Current Ratio 1.87
12 months ended Mar 31, 2013.
Trailing 12 month results shown above.
All data is in U.S. dollars.
- Assets $106,200,000,000
- Liabilities $50,594,000,000
- Liabilities-to-Equity Ratio 0.91
Price Ratios
- Price to Sales 3.06
- Price to Book 2.54
- Price to Cash Flow n/a
Event Calendar
| Event | Last | Next | ||
|---|---|---|---|---|
| Earnings | May 1 | $0.78 | Jul 26 | $0.83 |
| Surprises | May 1 | 8.97% | n/a | n/a |
| Dividends | Mar 13 | $0.43 | n/a | n/a |
| Splits | n/a | -- | n/a | n/a |
12 months ended May 23, 2013.
A look at major corporate events and financial announcements that are coming up.
Company Information
About the Company
Merck & Co., Inc. is a global research-driven pharmaceutical company dedicated to putting patients first. Established in 1891, Merck discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. The company devotes extensive efforts to increase access to medicines through far-reaching programs that not only donate Merck medicines but help deliver them to the people who need them. Merck also publishes unbiased health information as a not-for-profit service.
Officers
- Kenneth C. Frazier Chairman; President and Chief
- Peter N. Kellogg Executive Vice President and C
- Company Type: n/a
- Company Status: n/a
- Full-time Employees: n/a
-
Incorporation:
United States,
n/a -
Top 1000 Ranking:
Profit: n/a
Revenue: n/a
Assets: n/a
Head Office
ONE MERCK DRIVE P.O. BOX 100WHITEHOUSE STATION, NJ
08889-0
Phone: (908)-423-4840
Fax: (908)-7351253
Ideas & Discussion
Live Discussion of MRK on StockTwits